Viewing Study NCT07011056


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2025-12-25 @ 9:03 PM
Study NCT ID: NCT07011056
Status: RECRUITING
Last Update Posted: 2025-09-19
First Post: 2025-05-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module